Title:Progress and Prospects in Translating Nanobiotechnology in Medical Theranostics
Volume: 16
Issue: 5
Author(s): Amna Batool, Farid Menaa*, Bushra Uzair, Barkat Ali Khan and Bouzid Menaa
Affiliation:
- Department of Nanomedicine, California Innovations Corporation, San Diego, CA,United States
Keywords:
Nanotechnology, nanomedicine, nanotheranostics, nanoplatforms, nanodevices, nanomaterials, nanostructures,
nanosystems, translational medicine, innovation.
Abstract:
The pace at which nanotheranostic technology for human disease is evolving has
accelerated exponentially over the past five years. Nanotechnology is committed to utilizing the
intrinsic properties of materials and structures at submicroscopic-scale measures. Indeed, there is
generally a profound influence of reducing physical dimensions of particulates and devices on their
physico-chemical characteristics, biological properties, and performance. The exploration of nature’s
components to work effectively as nanoscaffolds or nanodevices represents a tremendous and
growing interest in medicine for various applications (e.g., biosensing, tunable control and targeted
drug release, tissue engineering). Several nanotheranostic approaches (i.e., diagnostic plus
therapeutic using nanoscale) conferring unique features are constantly progressing and overcoming
all the limitations of conventional medicines including specificity, efficacy, solubility, sensitivity,
biodegradability, biocompatibility, stability, interactions at subcellular levels.
This review introduces two major aspects of nanotechnology as an innovative and challenging
theranostic strategy or solution: (i) the most intriguing (bare and functionalized) nanomaterials with
their respective advantages and drawbacks; (ii) the current and promising multifunctional “smart”
nanodevices.